<p>Serum TGF-β1 concentrations (pg/mL) prior to TKA,then at 24 and 72 hours after TKA.</p
Serum levels of three biomarkers and cumulative amount of exsanguination during the 28-day period af...
<p>BAL fluid and serum samples were harvested and pooled on days 1, 7, 14, and 28 after DEP instilla...
<p>Descriptive statistics—Serum VEGF-A [pg/ml] concentrations before surgery, depending on the tumor...
<p>Serum TNF-α concentrations (pg/mL) prior to TKA,then at 24 and 72 hours after TKA.</p
<p>Serum IL-6 concentrations (pg/mL) prior to TKA, then at 24 and 72 hours after TKA.</p
<p>Serum IL-10 concentrations (pg/mL) prior to TKA,then at 24 and 72 hours after TKA.</p
<p>Plasma biomarker concentration (pg/ml) before (pre-treament) and after 28 days after sorafenib tr...
<p>The TGF-β1 concentration was determined using a quantitative ELISA for human TGF-β1. The results ...
<p>Measurements of total TGFβ levels were performed on plasma using an ELISA assay. Boxplots of base...
Levels of (A) IL-6 and (B) TNFα at baseline (day 0) and up to 14 days after TKA. *, p < 0.05 vs base...
Serum IgA seroconversion and mean concentration at Dose 1 and 28 days post-Dose 3.</p
Serum concentrations of creatine kinase, c-reactive protein, urea, free-testosterone and insulin-lik...
<p>Plasma TG(A) and glucose (B) concentrations on day 2 and 3 of the HIIE and control trials.</p
Serum GHBPs, IGFs and IGFBPs in congenital hypothyroidism during the first months of therap
<p>Serum level of TGF-β from control (white bars) and treated (black bars) after 4 and 6 weeks of tr...
Serum levels of three biomarkers and cumulative amount of exsanguination during the 28-day period af...
<p>BAL fluid and serum samples were harvested and pooled on days 1, 7, 14, and 28 after DEP instilla...
<p>Descriptive statistics—Serum VEGF-A [pg/ml] concentrations before surgery, depending on the tumor...
<p>Serum TNF-α concentrations (pg/mL) prior to TKA,then at 24 and 72 hours after TKA.</p
<p>Serum IL-6 concentrations (pg/mL) prior to TKA, then at 24 and 72 hours after TKA.</p
<p>Serum IL-10 concentrations (pg/mL) prior to TKA,then at 24 and 72 hours after TKA.</p
<p>Plasma biomarker concentration (pg/ml) before (pre-treament) and after 28 days after sorafenib tr...
<p>The TGF-β1 concentration was determined using a quantitative ELISA for human TGF-β1. The results ...
<p>Measurements of total TGFβ levels were performed on plasma using an ELISA assay. Boxplots of base...
Levels of (A) IL-6 and (B) TNFα at baseline (day 0) and up to 14 days after TKA. *, p < 0.05 vs base...
Serum IgA seroconversion and mean concentration at Dose 1 and 28 days post-Dose 3.</p
Serum concentrations of creatine kinase, c-reactive protein, urea, free-testosterone and insulin-lik...
<p>Plasma TG(A) and glucose (B) concentrations on day 2 and 3 of the HIIE and control trials.</p
Serum GHBPs, IGFs and IGFBPs in congenital hypothyroidism during the first months of therap
<p>Serum level of TGF-β from control (white bars) and treated (black bars) after 4 and 6 weeks of tr...
Serum levels of three biomarkers and cumulative amount of exsanguination during the 28-day period af...
<p>BAL fluid and serum samples were harvested and pooled on days 1, 7, 14, and 28 after DEP instilla...
<p>Descriptive statistics—Serum VEGF-A [pg/ml] concentrations before surgery, depending on the tumor...